Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs.
John J MarianiRobert L DobbinsAmy HeathFrank GrayHoward HassmanPublished in: The American journal on addictions (2023)
A prospective trial of participants grouped by fentanyl use status at induction demonstrates comparable patient retention and clinical response following single-day induction of BUP-XR in participants who are FEN+ and FEN-.
Keyphrases
- open label
- end stage renal disease
- clinical trial
- newly diagnosed
- phase iii
- ejection fraction
- phase ii
- study protocol
- chronic kidney disease
- prognostic factors
- case report
- peritoneal dialysis
- randomized controlled trial
- molecular docking
- squamous cell carcinoma
- patient reported outcomes
- radiation therapy
- molecular dynamics simulations
- rectal cancer
- locally advanced
- sensitive detection